Astrana Health, Inc.
ASTHNASDAQHealthcare● Active
$38.25
+$0.26(+0.69%)
Market Cap$1.9B
P/E Ratio—
52W High$39.93
52W Low$18.08
Astrana Health, Inc. (ASTH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ASTH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $0.77B |
| Cost of Revenue | $2.89B | $1.76B | $1.17B | $0.94B | $0.60B |
| Gross Profit | $0.30B | $0.27B | $0.21B | $0.20B | $0.18B |
| Gross Margin %(computed) | 9.30% | 13.34% | 15.50% | 17.43% | 22.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.22B | $0.15B | $0.11B | $0.08B | $0.06B |
| Total Operating Expenses | $0.22B | $0.18B | $0.13B | $0.10B | $0.08B |
| Operating Income | $0.08B | $0.09B | $0.08B | $0.10B | $0.10B |
| Operating Margin %(computed) | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.05B | $0.03B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.04B | $0.08B | $0.09B | $0.09B | $0.08B |
| Income Tax Expense | $0.02B | $0.03B | $0.03B | $0.04B | $0.03B |
| Net Income | $0.02B | $0.04B | $0.06B | $0.05B | $0.07B |
| Net Margin %(computed) | 0.71% | 2.12% | 4.38% | 3.95% | 8.91% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.46 | $0.91 | $1.30 | $1.00 | $1.57 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.04B | 0.04B |
| EBITDA | $0.12B | $0.14B | $0.12B | $0.11B | $0.10B |
| EBITDA Margin %(computed) | 3.91% | 6.97% | 8.92% | 9.80% | 13.01% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Astrana Health, Inc. data
About Astrana Health, Inc. (ASTH) Income Statement
Astrana Health, Inc. (ASTH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ASTH reported revenue of $3.18B, gross profit of $0.30B (gross margin 9.30%), and net income of $0.02B — a net profit margin of 0.71%.
Frequently asked questions
ASTH · 4 questionsAstrana Health, Inc. (ASTH) reported revenue of $3.18B for 2025, up 56.4% year-over-year.
ASTH revenueASTH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08